Low serum vitamin D is associated with axial length and risk of myopia in young children

European Journal of Epidemiology

Volumn 31, Issue 5, 2016, Pages 491-499

  Tideman, J Willem L ^a   Polling, Jan Roelof ^a,b   Voortman, Trudy ^a   Jaddoe, Vincent W V ^a   Uitterlinden, André G ^a   Hofman, Albert ^a   Vingerling, Johannes R ^a   Franco, Oscar H ^a   Klaver, Caroline C W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF APPLIED SCIENCES UTRECHT   (Netherlands)

Author keywords

Axial length; Children; Myopia; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; VITAMIN;

ARTICLE; CHILD; EYE AXIS LENGTH; EYE EXAMINATION; FEMALE; GENOTYPE; HETEROZYGOSITY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MYOPIA; QUESTIONNAIRE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; VISUAL ACUITY; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; COHORT ANALYSIS; COMPLICATION; ENVIRONMENT; EXERCISE; HEALTH SURVEY; LEISURE; LIFESTYLE; NETHERLANDS; PREVALENCE; VITAMIN D DEFICIENCY;

AXIAL LENGTH, EYE; CHILD; COHORT STUDIES; ENVIRONMENT; EXERCISE; FEMALE; HUMANS; LEISURE ACTIVITIES; LIFE STYLE; MALE; MYOPIA; NETHERLANDS; POPULATION SURVEILLANCE; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84960088911     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-016-0128-8     Document Type: Article

References (60)

1. Bar Dayan Y, Levin A, Morad Y, et al. The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Invest Ophthalmol Vis Sci. 2005;46(8):2760–5. doi:10.1167/iovs.04-0260.
2. Kim EC, Morgan IG, Kakizaki H, Kang S, Jee D. Prevalence and risk factors for refractive errors: Korean National Health and Nutrition Examination Survey 2008–2011. PLoS ONE. 2013;8(11):e80361. doi:10.1371/journal.pone.0080361.
3. Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971–1972 and 1999–2004. Arch Ophthalmol. 2009;127(12):1632–9. doi:10.1001/archophthalmol.2009.303.
4. French AN, Morgan IG, Burlutsky G, Mitchell P, Rose KA. Prevalence and 5- to 6-year incidence and progression of myopia and hyperopia in Australian schoolchildren. Ophthalmology. 2013;120(7):1482–91. doi:10.1016/j.ophtha.2012.12.018.
5. Zhan MZ, Saw SM, Hong RZ, et al. Refractive errors in Singapore and Xiamen, China—a comparative study in school children aged 6 to 7 years. Optom Vis Sci. 2000;77(6):302–8.
6. Williams KM, Verhoeven VJ, Cumberland P, et al. Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol. 2015;30(4):305–15. doi:10.1007/s10654-015-0010-0.
7. Jung SK, Lee JH, Kakizaki H, Jee D. Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South Korea. Invest Ophthalmol Vis Sci. 2012;53(9):5579–83. doi:10.1167/iovs.12-10106.
8. Saw SM. How blinding is pathological myopia? Br J Ophthalmol. 2006;90(5):525–6. doi:10.1136/bjo.2005.087999.
9. Hashemi H, Khabazkhoob M, Miraftab M, et al. Axial length to corneal radius of curvature ratio and refractive errors. J Ophthalmic Vis Res. 2013;8(3):220–6.
10. Ojaimi E, Rose KA, Morgan IG, et al. Distribution of ocular biometric parameters and refraction in a population-based study of Australian children. Invest Ophthalmol Vis Sci. 2005;46(8):2748–54. doi:10.1167/iovs.04-1324.
11. Jones LA, Mitchell GL, Mutti DO, Hayes JR, Moeschberger ML, Zadnik K. Comparison of ocular component growth curves among refractive error groups in children. Invest Ophthalmol Vis Sci. 2005;46(7):2317–27. doi:10.1167/iovs.04-0945.
12. Verhoeven VJ, Buitendijk GH, Consortium for Refractive E, et al. Education influences the role of genetics in myopia. Eur J Epidemiol. 2013;28(12):973–80. doi:10.1007/s10654-013-9856-1.
13. Stambolian D. Genetic susceptibility and mechanisms for refractive error. Clin Genet. 2013;84(2):102–8. doi:10.1111/cge.12180.
14. Sherwin JC, Reacher MH, Keogh RH, Khawaja AP, Mackey DA, Foster PJ. The association between time spent outdoors and myopia in children and adolescents: a systematic review and meta-analysis. Ophthalmology. 2012;119(10):2141–51. doi:10.1016/j.ophtha.2012.04.020.
15. Wu PC, Tsai CL, Wu HL, Yang YH, Kuo HK. Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology. 2013;120(5):1080–5. doi:10.1016/j.ophtha.2012.11.009.
16. Rose KA, Morgan IG, Ip J, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008;115(8):1279–85. doi:10.1016/j.ophtha.2007.12.019.
17. Dharani R, Lee CF, Theng ZX, et al. Comparison of measurements of time outdoors and light levels as risk factors for myopia in young Singapore children. Eye (Lond). 2012;26(7):911–8. doi:10.1038/eye.2012.49.
18. Jones-Jordan LA, Sinnott LT, Cotter SA, et al. Time outdoors, visual activity, and myopia progression in juvenile-onset myopes. Invest Ophthalmol Vis Sci. 2012;53(11):7169–75. doi:10.1167/iovs.11-8336.
19. Yazar S, Hewitt AW, Black LJ, et al. Myopia is associated with lower vitamin D status in young adults. Invest Ophthalmol Vis Sci. 2014;55(7):4552–9. doi:10.1167/iovs.14-14589.
20. Choi JA, Han K, Park YM, La TY. Low serum 25-hydroxyvitamin D is associated with myopia in Korean adolescents. Invest Ophthalmol Vis Sci. 2014;. doi:10.1167/iovs.13-12853.
21. Mutti DO, Cooper ME, Dragan E, et al. Vitamin D receptor (VDR) and group-specific component (GC, vitamin D-binding protein) polymorphisms in myopia. Invest Ophthalmol Vis Sci. 2011;52(6):3818–24. doi:10.1167/iovs.10-6534.
22. Annamaneni S, Bindu CH, Reddy KP, Vishnupriya S. Association of vitamin D receptor gene start codon (Fok1) polymorphism with high myopia. Oman J Ophthalmol. 2011;4(2):57–62. doi:10.4103/0974-620X.83654.
23. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81. doi:10.1056/NEJMra070553.
24. Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398–417. doi:10.1542/peds.2007-1894.
25. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4–8. doi:10.1016/j.pbiomolbio.2006.02.016.
26. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–1086S.
27. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr. 2008;88(6):1519–27. doi:10.3945/ajcn.2008.26182.
28. Moan J, Porojnicu AC, Dahlback A, Setlow RB. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci USA. 2008;105(2):668–73. doi:10.1073/pnas.0710615105.
29. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30(4):980–6. doi:10.2337/dc06-1994.
30. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36(5):1361–7. doi:10.2337/dc12-1050.
31. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135–41. doi:10.1001/archinternmed.2010.173.
32. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808–11. doi:10.1001/archneurol.2010.120.
33. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8(9):685–98. doi:10.1038/nri2378.
34. Fetahu IS, Hobaus J, Kallay E. Vitamin D and the epigenome. Front Physiol. 2014;5:164. doi:10.3389/fphys.2014.00164.
35. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C. Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids. 2001;66(3–5):171–6. doi:10.1016/S0039-128X(00)00200-2
36. Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27(9):739–56.
37. Kruithof CJ, Kooijman MN, van Duijn CM, et al. The Generation R Study: Biobank update 2015. Eur J Epidemiol. 2014;29(12):911–27. doi:10.1007/s10654-014-9980-6.
38. Camparini M, Cassinari P, Ferrigno L, Macaluso C. ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci. 2001;42(6):1226–31.
39. O’Donoghue L, Rudnicka AR, McClelland JF, Logan NS, Saunders KJ. Visual acuity measures do not reliably detect childhood refractive error—an epidemiological study. PLoS ONE. 2012;7(3):e34441. doi:10.1371/journal.pone.0034441.
40. Leone JF, Mitchell P, Morgan IG, Kifley A, Rose KA. Use of visual acuity to screen for significant refractive errors in adolescents: is it reliable? Arch Ophthalmol. 2010;128(7):894–9. doi:10.1001/archophthalmol.2010.134.
41. Voortman T, van den Hooven EH, Heijboer AC, Hofman A, Jaddoe VWV, Franco OH. Vitamin D deficiency in school-age children is associated with sociodemographic and lifestyle factors. J Nutr. 2015;145(4):791–8.
42. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography–tandem mass spectrometry. J Steroid Biochem Mol Biol. 2010;121(3–5):565–73. doi:10.1016/j.jsbmb.2010.02.025.
43. Yetley EA, Pfeiffer CM, Schleicher RL, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr. 2010;140(11):2030S–45S. doi:10.3945/jn.110.121483.
44. Tolppanen AM, Sayers A, Fraser WD, Lewis G, Zammit S, Lawlor DA. The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood—a prospective cohort study. J Child Psychol Psychiatry. 2012;53(7):757–66. doi:10.1111/j.1469-7610.2011.02518.x.
45. Morrison MA, Silveira AC, Huynh N, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011;5(6):538–68. doi:10.1186/1479-7364-5-6-538
46. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–8. doi:10.1016/S0140-6736(10)60588-0.
47. Allochtonen in Nederland 2004. Voorburg/Heerlen: Statistics Netherlands; 2004.
48. Ashby R, Ohlendorf A, Schaeffel F. The effect of ambient illuminance on the development of deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 2009;50(11):5348–54. doi:10.1167/iovs.09-3419.
49. Choi JA, Han K, Park YM, La TY. Low serum 25-hydroxyvitamin D is associated with myopia in Korean adolescents. Invest Ophthalmol Vis Sci. 2014;55(4):2041–7. doi:10.1167/IOVS.13-12853.
50. Guggenheim JA, Williams C, Northstone K, et al. Does vitamin D mediate the protective effects of time outdoors on myopia? Findings from a prospective birth cohort. Invest Ophthalmol Vis Sci. 2014;55(12):8550–8. doi:10.1167/iovs.14-15839.
51. Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res. 2013;114:106–19. doi:10.1016/j.exer.2013.02.007.
52. Luft WA, Iuvone PM, Stell WK. Spatial, temporal, and intensive determinants of dopamine release in the chick retina. Vis Neurosci. 2004;21(4):627–35. doi:10.1017/S0952523804214110.
53. Feldkaemper M, Diether S, Kleine G, Schaeffel F. Interactions of spatial and luminance information in the retina of chickens during myopia development. Exp Eye Res. 1999;68(1):105–15. doi:10.1006/exer.1998.0590.
54. Bloomfield SA, Volgyi B. The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci. 2009;10(7):495–506. doi:10.1038/nrn2636.
55. Oran M, Unsal C, Albayrak Y, et al. Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat. 2014;10:953–8. doi:10.2147/NDT.S63599.
56. Cass WA, Peters LE, Fletcher AM, Yurek DM. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats. Neurochem Res. 2014;39(8):1467–76. doi:10.1007/s11064-014-1331-1.
57. Jiang P, Zhang LH, Cai HL, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. 2014;6(12):6048–59. doi:10.3390/nu6126048.
58. Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS ONE. 2013;8(4):e62040. doi:10.1371/journal.pone.0062040.
59. de Borst MH, de Boer RA, Stolk RP, Slaets JP, Wolffenbuttel BH, Navis G. Vitamin D deficiency: universal risk factor for multifactorial diseases? Curr Drug Targets. 2011;12(1):97–106. doi:10.2174/138945011793591590
60. Alsalem JA, Patel D, Susarla R, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci. 2014;55(4):2140–7. doi:10.1167/iovs.13-13019.